February 2011 Issue of MMM
This month's cover story hails mobile apps as the future of patient education and disease management, which is a somewhat courageous statement.
Mobile apps are the future of patient education and disease management, promising better tracking, improved adherence and richer patient-doctor dialogue, reports Matthew Arnold
Lauren Folino and Tracy Peterson look back on the extraordinary lives of the three newest members of the Medical Advertising Hall of Fame
While healthcare reform presents issues and challenges for pharma, not to worry: reform also brings with it numerous opportunities to increase sales and market share
The MM&M Awards 2011 program is open for business. This is your chance to put your best work forward, showcase your talents and get the ...
Novo Nordisk has built a dizzyingly successful business on insulin sales (34 quarters of double-digit growth and counting), but when the company got into the ...
The patent cliffs for the two biggest cardiovascular products are due to arrive this year and next, paving the way for generics. But don't count ...
The last two years saw controversy regarding the drug approval process.
Johnson & Johnson has received a lot of criticism lately because of the McNeil recalls of cold medicines, especially those for children. Factories must follow ...
The FDA's point-man on prescription drugs, principal deputy commissioner Joshua Sharfstein, left the agency to head up public health in his home state of Maryland.
The 2nd US Circuit Court of Appeals heard oral arguments in Caronia vs. US on December 2, a case that challenges a sales rep's inability ...
Merck and GlaxoSmithKline are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies.
Featuring news about AxoGen, Veeva Systems, Veeva iRep and ReachMD
Med Ed Report
Proper disclosure and good faith efforts are apparently not enough to enforce university bans on paid speaking programs.
Accredited providers will be responsible for offering corrective information to learners, faculty and planners if an activity is found to break rules for independence, freedom ...
A 1998 Lancet paper that touched off a worldwide scare over the measles, mumps and rubella (MMR) vaccine was not only incorrect, claims an editorial ...
Featuring news about Lilly, American Medical Student Association and ReachMD
Doctors responding to an MM&M survey hosted by Sermo--a social network for practicing physicians--said they use the Epocrates mobile app more often for work purposes ...
Quadrant HealthCom brought Gary Falcetano back to the company as group publisher, overseeing Clinician Reviews, Convenient Care and Emergency Medicine. Falcetano left in 2008 and ...
One of the most important parts of the office visit in my practice is patient education. When a patient understands their diagnosis, they become an ...
Featuring news about Doctors.net.co.uk, Global Media Sante, Healthcare Information and Management System Society, MedTech Media and Elsevier
GlaxoSmithKline's decision in late 2010 to shift consumer media-planning and -buying duties for all its brands was a fresh signal that no media account is ...
Many Americans remain skeptical about the prospect of online consultations with their doctors and DIY testing via mobile apps, though men, younger and more affluent ...
A holiday digital campaign dubbed "Why the heck should I give to the Red Cross?" played off of an internet meme to raise awareness of ...
Featuring news about WebMD, Medscape, Manhattan Research and CVS Caremark
I wrote recently about the memorable campaign that AstraZeneca was running for Nexium, and this month I find myself applauding them for their DTC work ...
Sunovion Pharmaceuticals quietly mothballed a Lunesta TV ad that drew FDA scrutiny, in favor of a spot that reprises the sleep drug's familiar mascot.
GlaxoSmithKline has launched new commercials for Alli, just in time for holiday overeating remorse.
IMS Health said it signed a definitive agreement to acquire privately held insight and analytics company SDI Health, bringing together two of the largest pharmaceutical ...
Topiramate, the generic name for Ortho-McNeil/Janssen-Cilag's Topamax, is the sales leader among drugs approved for chronic migraine.
Steve Viviano was named president of Interpublic Group's Lowe Healthcare Worldwide and its advertising and marketing units, including a just-launched digital arm, MM&M has learned.
GlaxoSmithKline tapped Omnicom's PHD as media agency of record on all of its healthcare products, ousting incumbent WPP's MediaCom.
Featuring news about Publicis Healthcare Communicaitons Goup, inVentiv, GSW Worldwide and Burson-Marsteller
In January, FDA announced the launch of a new "FDA Basics for Industry," the most promising of its faltering transparency steps to date.
The life sciences industry is sitting on the sidelines and waiting for regulatory guidance, rather than jumping into wide-scale use of social media, according to ...
FDA associate commissioner for external affairs Beth Martino, a former Kansas aide to HHS secretary Kathleen Sebelius, has conducted an unprecedented purge of senior specialists, ...
In the past, whenever an ice age occurred, the natural selection process over species seemed to be kicked into overdrive.
The FDA's responsibility is first and foremost to public health and the promotion of safe and effective products.
It dawned on me at the New Year, that it was some 20 years ago that the Coalition for Healthcare Communication came into being.
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.
- Novartis psoriasis drug approval could upend market
- Sandoz gets ready to make the biosimilar case with oncologists
- Guidemark Health jumpstarts rebrand, brings on big-agency grad
- MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics
- Nurse practitioner workforce has just about doubled